PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.310
-0.030 (-2.24%)
At close: Nov 5, 2025, 4:00 PM EST
1.310
0.00 (0.01%)
After-hours: Nov 5, 2025, 5:20 PM EST
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $69.42 million as of November 5, 2025. Its market cap has decreased by -15.26% in one year.
Market Cap
69.42M
Enterprise Value
-77.87M
1-Year Change
-15.26%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $69.42M, a decrease of -95.70%. That is a compound annual growth rate of -45.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 69.42M | -11.16% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 833.27B |
| Johnson & Johnson | 448.92B |
| AbbVie | 383.43B |
| UnitedHealth Group | 296.20B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.84B |
| Thermo Fisher Scientific | 213.79B |